ArticleWorld journal of gastroenterology2019

Oncogenic ADAM28 induces gemcitabine resistance and predicts a poor prognosis in pancreatic cancer.

Li Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.